65 related articles for article (PubMed ID: 35693289)
1. Implementation of an ISO15189 accredited next-generation sequencing service with the fully automated Ion Torrent Genexus: the experience of a clinical diagnostic laboratory.
Werner R; Connolly A; Bennett M; Hand CK; Burke L
J Clin Pathol; 2024 Mar; 77(4):278-283. PubMed ID: 36522176
[TBL] [Abstract][Full Text] [Related]
2. Clinical validation of the Ion Torrent Oncomine Myeloid Assay GX v2 on the Genexus Integrated Sequencer as a stand-alone assay for single-nucleotide variants, insertions/deletions, and fusion genes: Challenges, performance, and perspectives.
Krishnamurthy K; Chai J; Liu X; Wang Y; Naeem R; Goldstein DY
Am J Clin Pathol; 2024 Jun; ():. PubMed ID: 38823030
[TBL] [Abstract][Full Text] [Related]
3. Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and Pitfalls.
Esposito Abate R; Frezzetti D; Maiello MR; Gallo M; Camerlingo R; De Luca A; De Cecio R; Morabito A; Normanno N
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33348595
[TBL] [Abstract][Full Text] [Related]
4. Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy.
Hovelson DH; Liu CJ; Wang Y; Kang Q; Henderson J; Gursky A; Brockman S; Ramnath N; Krauss JC; Talpaz M; Kandarpa M; Chugh R; Tuck M; Herman K; Grasso CS; Quist MJ; Feng FY; Haakenson C; Langmore J; Kamberov E; Tesmer T; Husain H; Lonigro RJ; Robinson D; Smith DC; Alva AS; Hussain MH; Chinnaiyan AM; Tewari M; Mills RE; Morgan TM; Tomlins SA
Oncotarget; 2017 Oct; 8(52):89848-89866. PubMed ID: 29163793
[TBL] [Abstract][Full Text] [Related]
5. Targeted Next-Generation Sequencing of Liquid Biopsy Samples from Patients with NSCLC.
Mellert H; Reese J; Jackson L; Maxwell V; Tschida C; Pestano GA
Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33494470
[TBL] [Abstract][Full Text] [Related]
6. Blood-Based Liquid Biopsy for Comprehensive Cancer Genomic Profiling Using Next-Generation Sequencing: An Emerging Paradigm for Non-invasive Cancer Detection and Management in Dogs.
Kruglyak KM; Chibuk J; McLennan L; Nakashe P; Hernandez GE; Motalli-Pepio R; Fath DM; Tynan JA; Holtvoigt LE; Chorny I; Grosu DS; Tsui DWY; Flory A
Front Vet Sci; 2021; 8():704835. PubMed ID: 34307538
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
Malapelle U; Leighl N; Addeo A; Hershkovitz D; Hochmair MJ; Khorshid O; Länger F; de Marinis F; Peled N; Sheffield BS; Smit EF; Viteri S; Wolf J; Venturini F; O'Hara RM; Rolfo C
Br J Cancer; 2024 May; ():. PubMed ID: 38750115
[TBL] [Abstract][Full Text] [Related]
8. Clinical validation of a blood-based liquid biopsy test integrating cell-free DNA quantification and next-generation sequencing for cancer screening in dogs.
Flory A; Ruiz-Perez CA; Clavere-Graciette AG; Rafalko JM; O'Kell AL; Flesner BK; McLennan LM; Hicks SC; Nakashe P; Phelps-Dunn A; DiMarzio LR; Warren CD; Cohen TA; Chibuk J; Chorny I; Grosu DS; Tsui DWY; Tynan JA; Kruglyak KM
J Am Vet Med Assoc; 2024 May; 262(5):665-673. PubMed ID: 38324993
[TBL] [Abstract][Full Text] [Related]
9. European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors.
Normanno N; Machado JC; Pescarmona E; Buglioni S; Navarro L; Esposito Abate R; Ferro A; Mensink R; Lambiase M; Lespinet-Fabre V; Calgua B; Jermann PM; Ilié M; Hofman P
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762091
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of patients with KRAS mutation detected by liquid biopsy.
Amino Y; Low SK; Ninomiya H; Kiritani A; Miyadera K; Kakuto S; Akita T; Tsugitomi R; Ariyasu R; Uchibori K; Kitazono S; Yanagitani N; Nishio M
Thorac Cancer; 2023 Nov; 14(33):3317-3322. PubMed ID: 37751775
[TBL] [Abstract][Full Text] [Related]
11. Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors.
Petaccia de Macedo M; Toledo Nascimento EC; Soares FA; Costa Santini F; D'Almeida Costa F; Werneck da Cunha I; Ramella Munhoz R; De Marchi P; Carnier Jorge TW; Ramos Moreira Leite K
Clin Pathol; 2023; 16():2632010X231197080. PubMed ID: 37719804
[TBL] [Abstract][Full Text] [Related]
12. An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples.
Bironzo P; Pepe F; Russo G; Pisapia P; Gragnano G; Aquino G; Bessi S; Buglioni S; Bartoccini F; Ferrero G; Bresciani MA; Francia di Celle P; Sibona F; Giusti A; Movilia A; Farioli RM; Santoro A; Salemi D; Scarpino S; Galafate D; Tommasi S; Lacalamita R; Seminati D; Sajjadi E; Novello S; Pagni F; Troncone G; Malapelle U
Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832117
[TBL] [Abstract][Full Text] [Related]
13. Retrospective Assessment of Complementary Liquid Biopsy on Tissue Single-Gene Testing for Tumor Genotyping in Advanced NSCLC.
Desmeules P; Dusselier M; Bouffard C; Bafaro J; Fortin M; Labbé C; Joubert P
Curr Oncol; 2023 Jan; 30(1):575-585. PubMed ID: 36661694
[TBL] [Abstract][Full Text] [Related]
14. Circulating Tumor DNA-Based Genomic Profiling Assays in Adult Solid Tumors for Precision Oncology: Recent Advancements and Future Challenges.
Chan HT; Chin YM; Low SK
Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805046
[TBL] [Abstract][Full Text] [Related]
15. Liquid biopsies come of age in lung cancer.
Christopoulos P
Transl Lung Cancer Res; 2022 May; 11(5):706-710. PubMed ID: 35693286
[No Abstract] [Full Text] [Related]
16. Rapid genomic profiling of circulating tumor DNA in non-small cell lung cancer using Oncomine Precision Assay with Genexus™ integrated sequencer.
Low SK; Ariyasu R; Uchibori K; Hayashi R; Chan HT; Chin YM; Akita T; Harutani Y; Kiritani A; Tsugitomi R; Manabe R; Ogusu S; Amino Y; Kitazono S; Yanagitani N; Nakamura Y; Nishio M
Transl Lung Cancer Res; 2022 May; 11(5):711-721. PubMed ID: 35693289
[TBL] [Abstract][Full Text] [Related]
17. Rapid detection of mutations in CSF-cfTNA with the Genexus Integrated Sequencer.
Arjuna S; Shah M; Dono A; Nunez-Rubiano L; Pichardo-Rojas PS; Zhu JJ; Riascos RF; Luthra R; Roy-Chowdhuri S; Duose D; Wang DH; Lang FF; Esquenazi Y; Ballester LY
J Neurooncol; 2024 Jan; 166(1):39-49. PubMed ID: 38160230
[TBL] [Abstract][Full Text] [Related]
18. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
